Table 2.

BMT CTN SOSS Committees and Reviewers

Committee/Position	Reviewers
Committee 1: Leukemia
Chair:	Steven Devine, Ohio State University Medical Center, Columbus
Members:	Frederick Appelbaum, Fred Hutchinson Cancer Research Center, Seattle Richard Champlin, MD Anderson Cancer Center, Houston Stephen Couban, Queen Elizabeth II Health Science Center, Halifax Marcos de Lima, Case Western Reserve University, Cleveland John DiPersio, Washington University, St. Louis Harry Erba, University of Alabama at Birmingham Timothy Graubert, Massachusetts General Hospital, Boston Guido Marcucci, Ohio State University Medical Center, Columbus Richard Stone, Dana-Farber Cancer Institute, Boston Martin Tallman, Memorial Sloan-Kettering Cancer Center, New York
Outside reviewers:	Donald Bunjes, University of Ulm Vanderson Rocha, Hôpital Saint-Louis, Paris
Committee 2: Lymphoma
Chair:	Ginna Laport, Stanford University, Palo Alto
Members:	Richard Ambinder, Johns Hopkins University, Baltimore Timothy Fenske, Medical College of Wisconsin, Milwaukee Richard Fisher, Fox Chase Cancer Center, Philadelphia Brad Kahl, University of Wisconsin, Madison John Leonard, Weill Cornell Medical College, New York Thomas Shea, University of North Carolina, Chapel Hill Julie Vose, University of Nebraska, Omaha Wyndham Wilson, National Institutes of Health, Bethesda
Outside reviewers:	Silvia Montoto, St. Bartholomew’s Hospital, London Eileen Smith, City of Hope, Duarte
Committee 3: Multiple Myeloma
Chair:	Sergio Giralt, Memorial Sloan-Kettering Cancer Center, New York
Members:	Kenneth Anderson, Dana-Farber Cancer Institute, Boston William Bensinger, Fred Hutchinson Cancer Research Center, Seattle Parameswaran Hari, Medical College of Wisconsin, Milwaukee Amrita Krishnan, City of Hope, Duarte Carl Ola Landgren, National Institutes of Health, Bethesda Sagar Lonial, Emory University, Atlanta Philip McCarthy, Roswell Park Cancer Institute, Buffalo Robert Orlowski, MD Anderson Cancer Center, Houston Vincent Rajkumar, Mayo Clinic, Rochester Keith Stewart, Mayo Clinic, Rochester
Outside reviewers:	Nicolaus Kroeger, University Medical Center Hamburg-Eppendorf Maria-Victoria Mateos, Salamanca University Hospital
Committee 4: Nonmalignant Disease
Chair:	Harold Atkins, Ottawa Hospital Research Institute
Members:	Joachim Deeg, Fred Hutchinson Cancer Research Center, Seattle George Georges, Fred Hutchinson Cancer Research Center, Seattle Linda Griffith, National Institute of Allergy & Infectious Diseases, Bethesda Carolyn Keever-Taylor, Medical College of Wisconsin, Milwaukee Richard Nash, Colorado Blood Cancer Institute, Denver Steven Pavletic, National Institutes of Health, Bethesda Michael Racke, Ohio State University Medical Center, Columbus Keith Sullivan, Duke University, Durham
Outside reviewers:	Harry Malech, National Institute of Allergy & Infectious Diseases, Bethesda Paolo Muraro, Imperial College/Hammersmith Hospital, London
Committee 5: Pediatric Transplantation – Indications/Approaches
Chair:	Michael Pulsipher, University of Utah, Salt Lake City
Members:	Stephan Grupp, Children’s Hospital of Philadelphia Robert Krance, Baylor College of Medicine, Houston Joanne Kurtzberg, Duke University, Durham John Levine, University of Michigan, Ann Arbor Parinda Mehta, Cincinnati’s Children’s Hospital Sung-Yun Pai, Dana-Farber Cancer Institute, Boston Kirk Schultz, University of British Columbia, Vancouver Shalini Shenoy, Washington University, St. Louis Michael Verneris, University of Minnesota, Minneapolis Donna Wall, Manitoba Institute of Child Health, Winnipeg
Outside reviewers:	Adriana Seber, Instituto de Oncologia Pediátrica, Sao Paolo Paul Veys, Great Ormond Street Hospital for Children, London
Committee 6: Pediatric Transplantation – Outcomes/Late Effects
Chair:	Stella Davies, Cincinnati’s Children’s Hospital Medical Center
Members:	Scott Baker, Fred Hutchinson Cancer Research Center, Seattle Farid Boulad, Memorial Sloan-Kettering Cancer Center, New York Paul Carpenter, Fred Hutchinson Cancer Research Center, Seattle Christine Duncan, Dana-Farber Cancer Institute, Boston Mary Eapen, Medical College of Wisconsin, Milwaukee David Jacobsohn, Children’s National Medical Center, Washington, DC Amy Keating, University of Colorado, Denver Carrie Kitko, University of Michigan, Ann Arbor Margaret MacMillan, University of Minnesota, Minneapolis
Outside reviewers:	Adriana Seber, Instituto de Oncologia Pediátrica. Sao Paolo Paul Veys, Great Ormond Street Hospital for Children, London
Committee 7: Optimal Donor and Graft Source
Chair:	Claudio Anasetti, H. Lee Moffitt Cancer Center, Tampa
Members:	Juliet Barker, Memorial Sloan-Kettering Cancer Center, New York Asad Bashey, Northside Hospital, Atlanta Claudio Brunstein, University of Minnesota, Minneapolis Dennis Confer, National Marrow Donor Program, Minneapolis Sarah Cooley, University of Minnesota, Minneapolis Corey Cutler, Dana-Farber Cancer Institute, Boston Ephraim Fuchs, Johns Hopkins University, Baltimore John Hansen, Fred Hutchinson Cancer Research Center, Seattle Elizabeth Shpall, MD Anderson Cancer Center, Houston
Outside reviewers:	Bronwen Shaw, Anthony Nolan Research Institute, London Gerard Socie, Hôpital Saint-Louis, Paris
Committee 8: GVHD
Chair:	Joseph Antin, Dana-Farber Cancer Institute, Boston
Members:	Amin Alousi, MD Anderson Cancer Center, Houston James Ferrara, University of Michigan, Ann Arbor Mary Flowers, Fred Hutchinson Cancer Research Center, Seattle Richard Jones, Johns Hopkins University, Baltimore Leslie Kean, Seattle Children’s Hospital Paul Martin, Fred Hutchinson Cancer Research Center, Seattle Richard Maziarz, Oregon Health & Science University, Portland David Porter, University of Pennsylvania, Philadelphia Daniel Weisdorf, University of Minnesota, Minneapolis
Outside reviewers:	Andrea Bacigalupo, San Martino Hospital, Genoa Ernst Holler, University Hospital Regensburg
Committee 9: Gene and Cell Therapy
Chair:	Helen Heslop, Baylor College of Medicine, Houston
Members:	Catherine Bollard, Children’s National Medical Center, Washington, DC Steve Forman, City of Hope, Duarte Edwin Horwitz, Children’s Hospital of Philadelphia Michael Jensen, Seattle Children’s Hospital Donald Kohn, University of California- Los Angeles Marcela Maus, University of Pennsylvania, Philadelphia Jeffery Miller, University of Minnesota, Minneapolis Katy Rezvani, MD Anderson Cancer Center, Houston Jerry Ritz, Dana-Farber Cancer Institute, Boston Michel Sadelain, Memorial Sloan-Kettering Cancer Center, New York
Outside reviewers:	Rupert Handgretinger, University of Tübingen Armand Keating, Princess Margaret Hospital, Toronto
Committee 10: Comorbidity and RRT
Chair:	Edward Stadtmauer, University of Pennsylvania, Philadelphia
Members:	Andrew Artz, University of Chicago Ami Bhatt, Dana-Farber Cancer Institute, Boston Guang-Shing Cheng, University of Washington, Seattle Kenneth Cooke, Johns Hopkins University, Baltimore Vincent Ho, Dana-Farber Cancer Institute, Boston John McCarty, Virginia Commonwealth University, Richmond Robert Soiffer, Dana-Farber Cancer Institute, Boston Mohamed Sorror, Fred Hutchinson Cancer Research Center, Seattle Greg Yanik, University of Michigan, Ann Arbor
Outside reviewers:	Jane Apperley, Imperial College, London Mohamad Mohty, Hotel-Dieu, Université de Nantes
Committee 11: Infection/Immune Reconstitution
Chair:	John Wingard, University of Florida, Gainesville
Members:	Michael Boeckh, Fred Hutchinson Cancer Research Center, Seattle Nelson Chao, Duke University, Durham Mitchell Horwitz, Duke University, Durham Kieren Marr, Johns Hopkins University, Baltimore Richard O’Reilly, Memorial Sloan-Kettering Cancer Center, New York Stan Riddell, Fred Hutchinson Cancer Research Center, Seattle Marcel van den Brink, Memorial Sloan-Kettering Cancer Center, New York Edmund Waller, Emory University, Atlanta
Outside reviewers:	Per Ljungman, Karolinska University Hospital, Huddinge John Zaia, City of Hope, Duarte
Committee 12: Late Effects/QOL/Economics
Chair:	Stephanie Lee, Fred Hutchinson Cancer Research Center, Seattle
Members:	Saro Armenian, City of Hope, Duarte Heather Jim, H. Lee Moffitt Cancer Center, Tampa Nandita Khera, Mayo Clinic, Rochester Navneet Majhail, National Marrow Donor Program, Minneapolis J. Douglas Rizzo, Medical College of Wisconsin, Milwaukee Bipin Savani, Vanderbilt University, Nashville Karen Syrjala, Fred Hutchinson Cancer Research Center, Seattle
Outside reviewers:	Jane Apperley, Imperial College, London Gerard Socie, Hôpital Saint-Louis, Paris
Committee 13: Clinical Trial Design
Chairs:	Brent Logan, Medical College of Wisconsin, Milwaukee Liaison to Comorbidity/RRT and Pediatric Outcomes/Late Effects Committee Marcelo Pasquini, Medical College of Wisconsin, Milwaukee Liaison to Gene/Cell Therapy and Multiple Myeloma Committees
Members:	Tom Braun, University of Michigan, Ann Arbor Liaison to Gene/Cell Therapy and GVHD Committees Nancy DiFronzo, National Heart, Lung, and Blood Institute, Bethesda Liaison to Nonmalignant Disease and Pediatric Outcomes/Late Effects Committees Elihu Estey, Fred Hutchinson Cancer Research Center, Seattle Liaison to Comorbidity/RRT and Leukemia Committees Nancy Geller, National Heart, Lung, and Blood Institute, Bethesda Liaison to GVHD and Multiple Myeloma Committees Ted Gooley, Fred Hutchinson Cancer Research Center, Seattle Liaison to Late Effect/QOL/Economics and Leukemia Committees Mary Horowitz, Medical College of Wisconsin, Milwaukee Liaison to Lymphoma and Pediatric Indications/Approaches Committees Eric Leifer, National Heart, Lung, and Blood Institute, Bethesda Liaison to Late Effects/QOL/Economic and Pediatric Outcomes/Late Effects Committees Leo Luznik, Johns Hopkins University, Baltimore Liaison to Infection/Immune Reconstitution and Optimal Donor/Graft Source Committees Adam Mendizabal, The EMMES Corporation, Rockville Liaison to Nonmalignant Diseases and Pediatric Indications/Approaches Committees Joycelynne Palmer, City of Hope, Duarte Liaison to Infection/Immune Reconstitution and Lymphoma Committees
Outside reviewers:	N/A